Scrotal fixation in the management of low undescended testes

por Sutton, Paul A., Greene, Owen J., Adamson, Louise, Singh, Shailinder Jit
Publicado 2011

Patients Undergoing Systemic Anti-Cancer Therapy Who Require Surgical Intervention: What Surgeons Need to Know

por Robinson, Matthew D., McNamara, Mairéad G., Clouston, Hamish W., Sutton, Paul A., Hubner, Richard A., Valle, Juan W.
Publicado 2023

Re-examining HSPC1 inhibitors

por Lee, Sheah Lin, Dempsey-Hibbert, Nina Claire, Vimalachandran, Dale, Wardle, Terence David, Sutton, Paul A., Williams, John H. H.
Publicado 2017

Fluorescence-guided surgery: comprehensive review

por Sutton, Paul A, van Dam, Martijn A, Cahill, Ronan A, Mieog, Sven, Polom, Karol, Vahrmeijer, Alexander L, van der Vorst, Joost
Publicado 2023

Critical considerations for targeting colorectal liver metastases with nanotechnology

por Arshad, Usman, Sutton, Paul A., Ashford, Marianne B., Treacher, Kevin E., Liptrott, Neill J., Rannard, Steve P., Goldring, Christopher E., Owen, Andrew
Publicado 2019

Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancer

por Jones, Robert P, Sutton, Paul A, Evans, Jonathan P, Clifford, Rachel, McAvoy, Andrew, Lewis, James, Rousseau, Abigail, Mountford, Roger, McWhirter, Derek, Malik, Hassan Z
Publicado 2017

Development of an orthotopic syngeneic murine model of colorectal cancer for use in translational research

por Evans, Jonathan P, Winiarski, Boleslaw K, Sutton, Paul A, Ressel, Lorenzo, Duckworth, Carrie A, Pritchard, D Mark, Palmer, Daniel H, Goldring, Christopher E, Kitteringham, Neil R
Publicado 2019

The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer

por Evans, Jonathan P., Winiarski, Boleslaw K., Sutton, Paul A., Jones, Robert P., Ressel, Lorenzo, Duckworth, Carrie A., Pritchard, D. Mark, Lin, Zhi-Xiu, Vicky, Fretwell L., Tweedle, Elizabeth M., Costello, Eithne, Goldring, Christopher E., Copple, Ian M., Park, B. Kevin, Palmer, Daniel H., Kitteringham, Neil R.
Publicado 2018

Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer

por Evans, Jonathan P., Winiarski, Boleslaw K., Sutton, Paul A., Jones, Robert P., Ressel, Lorenzo, Duckworth, Carrie A., Pritchard, D. Mark, Lin, Zhi-Xiu, Fretwell, Vicky L., Tweedle, Elizabeth M., Costello, Eithne, Goldring, Christopher E., Copple, Ian M., Park, B. Kevin, Palmer, Daniel H., Kitteringham, Neil R.
Publicado 2019